Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery

Sponsor
University of Alexandria
Study ID
NCT04110132
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Postoperative Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Ganglion impar block with Bupivacaine. — PROCEDURE
    Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Bupivacaine 0.5% 10ml. Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12 hours postoperative.
  • Ganglion impar block with normal saline — PROCEDURE
    Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal Saline 10ml Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12 hours postoperative.

Study Details

The aim of this study is to evaluate the ganglion Impar block in the prevention of postoperative pain after anal surgery.

Key Dates

First listed
Oct 1, 2019
Start date
Jul 1, 2028
Status verified
Mar 2025
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Ganglion impar block with Bupivacaine.
    Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Bupivacaine 0.5% 10ml. Patient will have hemorrhoidectomy.
  • Placebo Comparator: Ganglion impar block with Saline
    Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal Saline 10ml Patient will have hemorrhoidectomy.

Primary Outcome Measure

Postoperative pain [ Time Frame: 24 hours ]

Central Contacts

Related Studies